MT Med is a specialist medical practice in Floreffe. Private Limited, started on 5 October 2022, 1 establishment.

What is the address of MT Med?

The registered office of MT Med is located at Rue de Suarlée, Floriffoux 23, 5150 Floreffe.

Is MT Med still active?

Yes. According to the CBE (30 October 2026) MT Med is active, legal situation “Normale toestand”, started on 5 October 2022.

Is MT Med registered on Peppol?

Yes, MT Med is registered on the Peppol network with ID 0208:0791940563.

What is the enterprise number of MT Med?

The enterprise number of MT Med is BE0791940563.

When was MT Med founded?

MT Med was founded on 5 October 2022.

Who are the directors of MT Med?

According to the 2025 annual accounts, the directors of MT Med are: Thomas MAIRIAUX.

Is MT Med a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 October 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MT Med make in 2025?

MT Med posted a profit after taxes of € 86,847 in financial year 2025.

What is the revenue of MT Med?

As a small company, MT Med is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 131,756.

MT Med (Private Limited) - Floreffe - BE0791940563

Dossier MT Med, printed on 30 October 2026 from databakkes.be/en/0791940563/mt-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MT Med from Floreffe, company number BE0791940563, closed financial year 2025 with a result of € 86,847 after tax. For that financial year MT Med recorded a gross margin of € 131,756 and equity of € 133,241. Compared with financial year 2024, the result moved from € 76,561 to € 86,847. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Healthy

€ 133,241

▼ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,847

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 53,057

▼ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 66,971

€ 9,904 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 479

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,855

▼ 25% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 25,328 Gross margin 2022: € 25,328 First fiscal year in the series	€ 164,286 Gross margin 2023: € 164,286 ▲ € 138,958 vs 2022 (€ 25,328) Favourable step	€ 104,498 Gross margin 2024: € 104,498 ▼ 36% vs 2023 (€ 164,286) Unfavourable step	€ 131,756 Gross margin 2025: € 131,756 ▲ 26% vs 2024 (€ 104,498) Favourable step	▲ 26%
Profit after taxes	€ 15,593 Profit after taxes 2022: € 15,593 First fiscal year in the series	€ 120,740 Profit after taxes 2023: € 120,740 ▲ € 105,147 vs 2022 (€ 15,593) Favourable step	€ 76,561 Profit after taxes 2024: € 76,561 ▼ 37% vs 2023 (€ 120,740) Unfavourable step	€ 86,847 Profit after taxes 2025: € 86,847 ▲ 13% vs 2024 (€ 76,561) Favourable step	▲ 13%
Equity	€ 19,093 Equity 2022: € 19,093 First fiscal year in the series	€ 139,833 Equity 2023: € 139,833 ▲ € 120,740 vs 2022 (€ 19,093) Favourable step	€ 146,394 Equity 2024: € 146,394 ▲ 5% vs 2023 (€ 139,833) Favourable step	€ 133,241 Equity 2025: € 133,241 ▼ 9% vs 2024 (€ 146,394) Unfavourable step	▼ 9%
Total debts	€ 29,755 Total debts 2022: € 29,755 First fiscal year in the series	€ 22,852 Total debts 2023: € 22,852 ▼ 23% vs 2022 (€ 29,755) Favourable step	€ 17,801 Total debts 2024: € 17,801 ▼ 22% vs 2023 (€ 22,852) Favourable step	€ 133,605 Total debts 2025: € 133,605 ▲ € 115,804 vs 2024 (€ 17,801) Unfavourable step	▲ € 115,804
Cash	€ 13,005 Cash 2022: € 13,005 First fiscal year in the series	€ 69,134 Cash 2023: € 69,134 ▲ € 56,129 vs 2022 (€ 13,005) Favourable step	€ 73,603 Cash 2024: € 73,603 ▲ 6% vs 2023 (€ 69,134) Favourable step	€ 53,057 Cash 2025: € 53,057 ▼ 28% vs 2024 (€ 73,603) Unfavourable step	▼ 28%
Retained profit	€ 15,593 Retained profit 2022: € 15,593 First fiscal year in the series	€ 136,333 Retained profit 2023: € 136,333 ▲ € 120,740 vs 2022 (€ 15,593) Favourable step	€ 142,894 Retained profit 2024: € 142,894 ▲ 5% vs 2023 (€ 136,333) Favourable step	€ 129,741 Retained profit 2025: € 129,741 ▼ 9% vs 2024 (€ 142,894) Unfavourable step	▼ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 70,000 Dividend 2024: € 70,000 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▲ 43% vs 2024 (€ 70,000) Unchanged	▲ 43%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 66,971 Bank debt 2025: € 66,971 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 48,848 Balance sheet total 2022: € 48,848 First fiscal year in the series	€ 162,685 Balance sheet total 2023: € 162,685 ▲ 233% vs 2022 (€ 48,848) Unchanged	€ 164,195 Balance sheet total 2024: € 164,195 ▲ 1% vs 2023 (€ 162,685) Unchanged	€ 266,846 Balance sheet total 2025: € 266,846 ▲ 63% vs 2024 (€ 164,195) Unchanged	▲ 63%

Key figures of MT Med, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MT Med?

What happened at MT Med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 16, 2026 New annual accounts for financial year 2025: profit of € 86,847 (▲ 13% vs 2024). Source: NBB ↗
Oct 5, 2022 New establishment in Floreffe. KBO
Oct 5, 2022 Start of the company according to the CBE. KBO

In short

From € 15,593 profit in 2022 to € 86,847 profit in 2025.

Paid € 87,667 in corporate taxes since 2022.

Best year ever: 2023, with € 120,740 profit.

Paid out € 170,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Thomas MAIRIAUX

MT Med

Behind MT Med is Thomas MAIRIAUX.

Directors

According to the 2025 annual accounts

Thomas MAIRIAUX

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Suarlée, Floriffoux 23

5150 Floreffe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0791.940.563
VAT number: BE 0791.940.563
Registered office: Rue de Suarlée, Floriffoux 23, 5150 Floreffe
Names & denominations: MT Med
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 October 2022
Peppol: Active · Active since 17 Jun 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗